ArticleJournal of clinical and experimental hematopathology : JCEH

Poor response to daratumumab and carfilzomib in newly diagnosed anaplastic multiple myeloma.

Masuho Saburi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.